
GMP Guide: Chapter 1
(Pharmaceutical Quality System)
Target date
|
Q4 2023
|
Comments
|
To provide the European Commission with a final text for the amended chapter in order to encourage industry adoption of risk-based approaches to prevention of shortages, taking account initiatives such as HMA-EMA Taskforce and the industry inter-association guidelines.
|
GMP
Guide: Chapter 4 (Documentation)
Target date
|
Q4 2023
|
Comments
|
To provide the European Commission with a final text for the amended chapter in order to assure data integrity in the context of GMP. This would be in parallel with similar consideration of Annex 11 (Computerised Systems).
|
GMP
Guide: Annex 11 (Computerised Systems)
Target date
|
Q4 2022
|
Comments
|
To provide the European Commission with a final text for the amended annex in order to assure data integrity in the context of GMP. This would be in parallel with similar consideration of Chapter 4 (Documentation).
|
GMP
Guide: Annex 15 Qualification and Validation
Target date
|
Q2 2023
|
Comments
|
Review the annex in the light of new technology in facilities, products and processes and consider whether any updates are necessary. Following up on LLE recommendations, consider whether the scope can be extended to APIs.
|
GMP
Guide: Annex 16 Certification by a Qualified Person and Batch Release
Target date
|
Q2 2023
|
Comments
|
Following up on LLE recommendations, consider revision of annex in order to provide additional guidance on batch traceability.
|
GMP
and Marketing Authorisation Holders
Target date
|
Q4 2023
|
Comments
|
To revise the paper in line with recommendations from the Nitrosamines LLE, to strengthen guidance for MAHs in terms of having adequate quality agreement with manufactures.
|